Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2

Ke Liu,Rongfeng Zou,Wenqiang Cui,Meiqing Li,Xueying Wang,Junlin Dong,Hongchun Li,Hongpei Li,Peihui Wang,Ximing Shao,Wu Su,H. C. Stephen Chan,Hongchang Li,Shuguang Yuan

Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2

2020

Ke Liu
Rongfeng Zou
Wenqiang Cui
Meiqing Li
Xueying Wang
Junlin Dong
Hongchun Li
Hongpei Li
Peihui Wang
Ximing Shao
Wu Su
H. C. Stephen Chan
Hongchang Li
Shuguang Yuan

The outbreak of COVID-19 by the end of 2019 has posed serious health threats to humanity and jeopardized the global economy. However, no effective drugs are available to treat COVID-19 currently an...

Keywords:

Coronavirus disease 2019
severe acute respiratory syndrome coronavirus 2
Outbreak
Intensive care medicine
Romidepsin
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations